<DOC>
	<DOCNO>NCT02304887</DOCNO>
	<brief_summary>The relationship osteoporosis drug kidney damage unclear . In study , plan reveal relationship osteoporosis drug kidney damage .</brief_summary>
	<brief_title>The Relationship Between Residual Renal Function Osteoporosis Treatment</brief_title>
	<detailed_description>Chronic kidney disease ( CKD ) - mineral bone disorder ( CKD-MBD ) one topic osteoporosis treatment . As many osteoporotic patient old , many patient deterioration renal function . In addition , several drug might potential kidney damage . But relationship osteoporosis drug kidney damage unclear . The main objective study reveal relationship osteoporosis drug kidney damage .</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Denosumab</mesh_term>
	<mesh_term>Teriparatide</mesh_term>
	<mesh_term>Selective Estrogen Receptor Modulators</mesh_term>
	<criteria>Osteoporosis patient eGFR &lt; 15</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Osteoporosis</keyword>
	<keyword>Bone mineral densisty</keyword>
	<keyword>Renal function</keyword>
	<keyword>CKD-MBD</keyword>
</DOC>